NCT05888675View on ClinicalTrials.gov

Clinical Study of Weifuchun Treatment on Gastric Cancer

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

July 1, 2016

Primary Completion Date

October 1, 2020

Study Completion Date

October 1, 2020

Conditions
Gastric Cancer (Diagnosis)
Interventions
DRUG

Weifuchun

The treatment group#Weifuchun group#was given Weifuchun tablets, 4 tablets each time, 3 times a day, and 1 hour after meals. The control group(chemotherapy group)#Chemotherapy regimen was based on the Chinese Clinical Oncology Association Guidelines for the Diagnosis and Treatment of Gastric Cancer (2018), including oxaliplatin +5-FU/CF, SOX regimen, XELOX regimen, and Ticeo monotherapy regimen.

All Listed Sponsors
lead

ShuGuang Hospital

OTHER

NCT05888675 - Clinical Study of Weifuchun Treatment on Gastric Cancer | Biotech Hunter | Biotech Hunter